Physician profile
Gianni Franceschi
NPI 1437565579
$2,588.15
in general payments reported to CMS, 2019-2025
8 companies · $40.00 in 2025
The $40.00 reported for 2025 was less than what a typical Dentist provider received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $115 · 2020: $516 · 2021: $450 · 2022: $1,011 · 2023: $382 · 2024: $75.00 · 2025: $40.00.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $415 · Long Term Medical Supply Or Device Loan: $59.00 · Food and Beverage: $22.64.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $415.00 |
| Long Term Medical Supply Or Device Loan | $59.00 |
| Food and Beverage | $22.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Midmark Corporation | $1,010.57 | 2022 | |
| Zimmer Biomet Holdings, INC. | $950.00 | 2020-2021 | |
| Zimvie INC. | $375.00 | 2023-2024 | |
| Straumann USA LLC | $72.64 | 2019-2023 | |
| Neoss, INC. | $59.00 | 2023 | Neoss Implant System |
| Orapharma, A Division of Bausch Health US, LLC | $48.52 | 2019-2020 | |
| Hu-Friedy Mfg. Co., LLC | $40.00 | 2025 | |
| Henry Schein, INC. | $32.42 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gianni Franceschi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.